[go: up one dir, main page]

ES2104917T3 - Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos. - Google Patents

Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos.

Info

Publication number
ES2104917T3
ES2104917T3 ES92910298T ES92910298T ES2104917T3 ES 2104917 T3 ES2104917 T3 ES 2104917T3 ES 92910298 T ES92910298 T ES 92910298T ES 92910298 T ES92910298 T ES 92910298T ES 2104917 T3 ES2104917 T3 ES 2104917T3
Authority
ES
Spain
Prior art keywords
bis
naftalimidas
thioamido
links
cancer agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92910298T
Other languages
English (en)
Inventor
Jung-Hui Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of ES2104917T3 publication Critical patent/ES2104917T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/14Aza-phenalenes, e.g. 1,8-naphthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTAN NUEVOS COMPUESTOS BISNAFTALIMIDA UTILES COMO AGENTES ANTITUMORALES, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y PROCESOS PARA LA PREPARACION DE DICHOS COMPUESTOS.
ES92910298T 1991-03-27 1992-03-25 Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos. Expired - Lifetime ES2104917T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/676,062 US5206250A (en) 1991-03-27 1991-03-27 Bis-naphthalimides containing amide and thioamide linkers as anticancer agents

Publications (1)

Publication Number Publication Date
ES2104917T3 true ES2104917T3 (es) 1997-10-16

Family

ID=24713079

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92910298T Expired - Lifetime ES2104917T3 (es) 1991-03-27 1992-03-25 Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos.

Country Status (10)

Country Link
US (1) US5206250A (es)
EP (1) EP0577745B1 (es)
JP (1) JP2701980B2 (es)
AT (1) ATE156481T1 (es)
AU (1) AU1752592A (es)
CA (1) CA2106996A1 (es)
DE (1) DE69221473T2 (es)
DK (1) DK0577745T3 (es)
ES (1) ES2104917T3 (es)
WO (1) WO1992017454A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69211567T2 (de) * 1991-12-11 1996-10-10 Du Pont Merck Pharma Hochwasserlösliche bis-naphthalimide-derivate nützlich als krebsmittel
US5235045A (en) * 1992-03-19 1993-08-10 Microbiomed Corporation Non-azo naphthalimide dyes
US5359070A (en) * 1993-02-11 1994-10-25 The Du Pont Merck Pharmaceutical Company Unsymmetrical bis-imides as anticancer agents
US5416089A (en) * 1993-06-24 1995-05-16 The Du Pont Merck Pharmaceutical Company Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
US5766600A (en) * 1993-08-09 1998-06-16 Microbiomed Corporation Non-azo naphtalimide dyes and uses for same
WO1995008539A1 (en) * 1993-09-24 1995-03-30 The Du Pont Merck Pharmaceutical Company Improved methods for preparing bis-imide compounds
US5561042A (en) * 1994-07-22 1996-10-01 Cancer Therapy And Research Center Diamine platinum naphthalimide complexes as antitumor agents
US5604095A (en) * 1994-07-22 1997-02-18 Cancer Therapy & Research Center Unsymmetrically linked bisnaphthalimides as antitumor agents
US5641782A (en) * 1995-02-16 1997-06-24 The Dupont Merck Pharmaceutical Company 3-aromatic and 3-heteroaromatic substituted bisnaphthalimides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146720A (en) * 1976-10-27 1979-03-27 Laboratorios Made, S.A. N-aminoethyl-substituted-3-nitronaphthalimides
ES459497A1 (es) * 1977-06-04 1978-04-16 Made Labor Sa Un metodo para la preparacion industrial de naftalimidas y sus derivados.
EP0125439B1 (en) * 1983-04-01 1990-01-24 Warner-Lambert Company 3,6-disubstituted-1,8-naphthalimides and methods for their production and use
DE3604827A1 (de) * 1986-02-15 1987-08-20 Bayer Ag Elektrophotographische toner
DE3707651A1 (de) * 1987-03-10 1988-09-22 Knoll Ag Bis-naphthalimide, ihre herstellung und verwendung
US5086059A (en) * 1990-06-07 1992-02-04 Du Pont Merck Pharmaceutical Company Bis-naphthalimides as anticancer agents

Also Published As

Publication number Publication date
DE69221473T2 (de) 1998-01-22
WO1992017454A1 (en) 1992-10-15
ATE156481T1 (de) 1997-08-15
DK0577745T3 (da) 1997-09-22
EP0577745A1 (en) 1994-01-12
CA2106996A1 (en) 1992-09-28
EP0577745B1 (en) 1997-08-06
DE69221473D1 (de) 1997-09-11
JPH06506226A (ja) 1994-07-14
AU1752592A (en) 1992-11-02
US5206250A (en) 1993-04-27
JP2701980B2 (ja) 1998-01-21

Similar Documents

Publication Publication Date Title
MX9304581A (es) Desoxitaxoles y composiciones farmaceuticas que los contienen
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
MX9300498A (es) Derivados de n-sulfonil-2-oxo-indol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
DK398587D0 (da) Antitumorvirksomt laegemiddel
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
SE9704546D0 (sv) Novel compounds
FI952248L (fi) Kasvainvastaisia koostumuksia, jotka sisältävät taksaanijohdannaisia
MX9301129A (es) Nuevas ciclosporinas y composiciones farmaceuticas que las contienen.
AR031975A1 (es) Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene
KR960702830A (ko) 방사선 보호제로서의 N-알킬티오 폴리아민 유도체(N-Alkylthio polyaine derivatives as radioprotective agents)
ES2104917T3 (es) Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos.
ES2179529T3 (es) Compuestos biaromaticos unidos por un radical heteroetinileno, y composiciones farmaceuticas y cosmeticas que los contienen.
ES2173556T3 (es) Nuevos compuestos heterociclicos, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
DK0579939T3 (da) Phospholipidderivater
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2162986T3 (es) Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
MX9206365A (es) Tetrahidrobenzotienopiridinas,proceso para su preparacion y composicion farmaceutica que las contiene
ES2146722T3 (es) Nuevos analogos de la acronicina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
FI874653A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-acylerade derivat av bis (2-imidazolin-2-ylhydrazoner) av 9,10-antracendikarboxialdehyd.
SE9803277D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 577745

Country of ref document: ES